Literature DB >> 21047792

Acute down-regulation of sodium-dependent phosphate transporter NPT2a involves predominantly the cAMP/PKA pathway as revealed by signaling-selective parathyroid hormone analogs.

So Nagai1, Makoto Okazaki, Hiroko Segawa, Clemens Bergwitz, Thomas Dean, John T Potts, Matthew J Mahon, Thomas J Gardella, Harald Jüppner.   

Abstract

The parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor (PTHR1) in cells of the renal proximal tubule mediates the reduction in membrane expression of the sodium-dependent P(i) co-transporters, NPT2a and NPT2c, and thus suppresses the re-uptake of P(i) from the filtrate. In most cell types, the liganded PTHR1 activates Gα(S)/adenylyl cyclase/cAMP/PKA (cAMP/PKA) and Gα(q/11)/phospholipase C/phosphatidylinositol 1,4,5-trisphosphate (IP(3))/Ca(2+)/PKC (IP(3)/PKC) signaling pathways, but the relative roles of each pathway in mediating renal regulation P(i) transport remain uncertain. We therefore explored the signaling mechanisms involved in PTH-dependent regulation of NPT2a function using potent, long-acting PTH analogs, M-PTH(1-28) (where M = Ala(1,12), Aib(3), Gln(10), Har(11), Trp(14), and Arg(19)) and its position 1-modified variant, Trp(1)-M-PTH(1-28), designed to be phospholipase C-deficient. In cell-based assays, both M-PTH(1-28) and Trp(1)-M-PTH(1-28) exhibited potent and prolonged cAMP responses, whereas only M-PTH(1-28) was effective in inducing IP(3) and intracellular calcium responses. In opossum kidney cells, a clonal cell line in which the PTHR1 and NPT2a are endogenously expressed, M-PTH(1-28) and Trp(1)-M-PTH(1-28) each induced reductions in (32)P uptake, and these responses persisted for more than 24 h after ligand wash-out, whereas that of PTH(1-34) was terminated by 4 h. When injected into wild-type mice, both M-modified PTH analogs induced prolonged reductions in blood P(i) levels and commensurate reductions in NPT2a expression in the renal brush border membrane. Our findings suggest that the acute down-regulation of NPT2a expression by PTH ligands involves mainly the cAMP/PKA signaling pathway and are thus consistent with the elevated blood P(i) levels seen in pseudohypoparathyroid patients, in whom Gα(s)-mediated signaling in renal proximal tubule cells is defective.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21047792      PMCID: PMC3020770          DOI: 10.1074/jbc.M110.198416

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations.

Authors:  Alessandro Bisello; Michael Chorev; Michael Rosenblatt; Luca Monticelli; Dale F Mierke; Serge L Ferrari
Journal:  J Biol Chem       Date:  2002-07-09       Impact factor: 5.157

2.  Residue 19 of the parathyroid hormone (PTH) modulates ligand interaction with the juxtamembrane region of the PTH-1 receptor.

Authors:  Masaru Shimizu; Naoto Shimizu; Janet C Tsang; Brian D Petroni; Ashok Khatri; John T Potts; Thomas J Gardella
Journal:  Biochemistry       Date:  2002-11-05       Impact factor: 3.162

3.  Enhanced activity in parathyroid hormone-(1-14) and -(1-11): novel peptides for probing ligand-receptor interactions.

Authors:  M Shimizu; P H Carter; A Khatri; J T Potts; T J Gardella
Journal:  Endocrinology       Date:  2001-07       Impact factor: 4.736

4.  Immunohistochemical identification of the PTHR1 parathyroid hormone receptor in normal and neoplastic human tissues.

Authors:  Amelie Lupp; Christoph Klenk; Christoph Röcken; Matthias Evert; Christian Mawrin; Stefan Schulz
Journal:  Eur J Endocrinol       Date:  2010-02-15       Impact factor: 6.664

5.  The opossum kidney cell type IIa Na/P(i) cotransporter is a phosphoprotein.

Authors:  M Jankowski; H Hilfiker; J Biber; H Murer
Journal:  Kidney Blood Press Res       Date:  2001       Impact factor: 2.687

Review 6.  Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting.

Authors:  L S Weinstein; S Yu; D R Warner; J Liu
Journal:  Endocr Rev       Date:  2001-10       Impact factor: 19.871

7.  A dual mechanism for regulation of kidney phosphate transport by parathyroid hormone.

Authors:  J A Cole; S L Eber; R E Poelling; P K Thorne; L R Forte
Journal:  Am J Physiol       Date:  1987-08

8.  Na+/H+ exchanger-regulatory factor 1 mediates inhibition of phosphate transport by parathyroid hormone and second messengers by acting at multiple sites in opossum kidney cells.

Authors:  Matthew J Mahon; Judith A Cole; Eleanor D Lederer; Gino V Segre
Journal:  Mol Endocrinol       Date:  2003-07-24

9.  Na(+)/H(+ ) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling.

Authors:  Matthew J Mahon; Mark Donowitz; C Chris Yun; Gino V Segre
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

10.  Effects of dibutyryl cyclic adenosine 3',5'-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism.

Authors:  N H Bell; S Avery; T Sinha; C M Clark; D O Allen; C Johnston
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

View more
  20 in total

1.  Convergent Signaling Pathways Regulate Parathyroid Hormone and Fibroblast Growth Factor-23 Action on NPT2A-mediated Phosphate Transport.

Authors:  W Bruce Sneddon; Giovanni W Ruiz; Luciana I Gallo; Kunhong Xiao; Qiangmin Zhang; Youssef Rbaibi; Ora A Weisz; Gerard L Apodaca; Peter A Friedman
Journal:  J Biol Chem       Date:  2016-07-18       Impact factor: 5.157

2.  1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice.

Authors:  Janaina S Martins; Eva S Liu; W Bruce Sneddon; Peter A Friedman; Marie B Demay
Journal:  Endocrinology       Date:  2019-10-01       Impact factor: 4.736

3.  NHERF-1 and the regulation of renal phosphate reabsoption: a tale of three hormones.

Authors:  Edward J Weinman; Eleanor D Lederer
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-25

4.  Renal phosphate wasting in the absence of adenylyl cyclase 6.

Authors:  Robert A Fenton; Fiona Murray; Jessica A Dominguez Rieg; Tong Tang; Moshe Levi; Timo Rieg
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

5.  Ezrin-anchored protein kinase A coordinates phosphorylation-dependent disassembly of a NHERF1 ternary complex to regulate hormone-sensitive phosphate transport.

Authors:  Bin Wang; Chris K Means; Yanmei Yang; Tatyana Mamonova; Alessandro Bisello; Daniel L Altschuler; John D Scott; Peter A Friedman
Journal:  J Biol Chem       Date:  2012-05-24       Impact factor: 5.157

Review 6.  Regulation of renal phosphate handling: inter-organ communication in health and disease.

Authors:  Sawako Tatsumi; Atsumi Miyagawa; Ichiro Kaneko; Yuji Shiozaki; Hiroko Segawa; Ken-Ichi Miyamoto
Journal:  J Bone Miner Metab       Date:  2015-08-22       Impact factor: 2.626

Review 7.  GPCR Signaling and Trafficking: The Long and Short of It.

Authors:  Nathan J Pavlos; Peter A Friedman
Journal:  Trends Endocrinol Metab       Date:  2016-11-23       Impact factor: 12.015

Review 8.  Heterotrimeric G proteins in the control of parathyroid hormone actions.

Authors:  Murat Bastepe; Serap Turan; Qing He
Journal:  J Mol Endocrinol       Date:  2017-05       Impact factor: 5.098

9.  Pharmacological Npt2a Inhibition Causes Phosphaturia and Reduces Plasma Phosphate in Mice with Normal and Reduced Kidney Function.

Authors:  Linto Thomas; Jianxiang Xue; Sathish Kumar Murali; Robert A Fenton; Jessica A Dominguez Rieg; Timo Rieg
Journal:  J Am Soc Nephrol       Date:  2019-08-13       Impact factor: 10.121

10.  Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH.

Authors:  Akira Maeda; Makoto Okazaki; David M Baron; Thomas Dean; Ashok Khatri; Mathew Mahon; Hiroko Segawa; Abdul B Abou-Samra; Harald Jüppner; Kenneth D Bloch; John T Potts; Thomas J Gardella
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.